- Home
- LX vs MDXG Comparison
LX vs MDXG Comparison
Compare LX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LX
- MDXG
- Stock Information
- Founded
- LX 2013
- MDXG 2006
- Country
- LX China
- MDXG United States
- Employees
- LX N/A
- MDXG N/A
- Industry
- LX Finance: Consumer Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- LX Finance
- MDXG Health Care
- Exchange
- LX Nasdaq
- MDXG Nasdaq
- Market Cap
- LX 1.1B
- MDXG 1.1B
- IPO Year
- LX 2017
- MDXG N/A
- Fundamental
- Price
- LX $5.86
- MDXG $6.94
- Analyst Decision
- LX
- MDXG Buy
- Analyst Count
- LX 0
- MDXG 1
- Target Price
- LX N/A
- MDXG $12.00
- AVG Volume (30 Days)
- LX 2.8M
- MDXG 439.7K
- Earning Date
- LX 08-07-2025
- MDXG 10-29-2025
- Dividend Yield
- LX 6.62%
- MDXG N/A
- EPS Growth
- LX 86.38
- MDXG N/A
- EPS
- LX 1.28
- MDXG 0.21
- Revenue
- LX $1,956,013,429.00
- MDXG $363,774,000.00
- Revenue This Year
- LX $5.90
- MDXG $12.68
- Revenue Next Year
- LX $21.30
- MDXG $8.18
- P/E Ratio
- LX $4.44
- MDXG $32.78
- Revenue Growth
- LX 0.80
- MDXG 6.85
- 52 Week Low
- LX $1.63
- MDXG $5.47
- 52 Week High
- LX $11.64
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- LX 41.36
- MDXG 46.17
- Support Level
- LX $5.62
- MDXG $6.89
- Resistance Level
- LX $5.94
- MDXG $7.14
- Average True Range (ATR)
- LX 0.20
- MDXG 0.18
- MACD
- LX -0.02
- MDXG -0.04
- Stochastic Oscillator
- LX 32.21
- MDXG 29.55
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.